Is MSB up or down today?
MSB is down 2.26% today, last at 17.71. This stock moved -2.26% versus the prior close.
MSB · MSB
MSB (MSB) is trading at 17.71, down 2.26% on the session. MSB sits at the 2% mark of its 52-week range, carries a 14-day RSI of 37, and trades below its 50-day average. Over the past month it is down 7.28%.
Leading the coverage: “Mesoblast Limited (ASX:MSB): What Do RYONCIL Sales and Clinical Milestones Mean for FY27? - Kalkine” (Google News Earnings, 4d ago). MSB is -1.99% since story.
MSB trades on a trailing P/E of 35.8 and is running 6.20% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
MSB is down 2.26% today, last at 17.71. This stock moved -2.26% versus the prior close.
Leading the coverage: “Mesoblast Limited (ASX:MSB): What Do RYONCIL Sales and Clinical Milestones Mean for FY27? - Kalkine” (Google News Earnings, 4d ago). MSB is -1.99% since story. Dominant story: Can Cochlear (ASX:COH) and Mesoblast (ASX:MSB) Lead ASX 100 Healthcare Revenue Growth? - Kalkine Media (1 source, bullish) RSI is 37 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (126 days) · Drag or scroll left for earlier dates
Can Cochlear (ASX:COH) and Mesoblast (ASX:MSB) Lead ASX 100 Healthcare Revenue Growth? - Kalkine Media
Mesabi Trust (MSB) Seasonal Returns Chart - Yahoo Finance - Yahoo! Finance Canada
Mesabi Trust stock awaits royalty report after payout suspension - ad-hoc-news.de
Mesoblast Limited (ASX:MSB): RYONCIL Revenue and Cash Spending in Focus - Kalkine
Mesoblast Limited (ASX:MSB): What Do Ryoncil Revenue and September-Quarter Cash Flows Reveal? - Kalkine